Perceptive Advisors LLC Has $7.25 Million Stake in Billiontoone, Inc. $BLLN

Perceptive Advisors LLC raised its position in shares of Billiontoone, Inc. (NASDAQ:BLLN) by 26.1% during the first quarter, HoldingsChannel.com reports. The fund owned 91,812 shares of the company’s stock after buying an additional 19,000 shares during the quarter. Perceptive Advisors LLC’s holdings in Billiontoone were worth $7,248,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Rossby Financial LCC bought a new stake in shares of Billiontoone during the 4th quarter valued at about $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone during the fourth quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new stake in Billiontoone in the fourth quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone in the fourth quarter valued at approximately $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone in the fourth quarter valued at approximately $201,000.

Billiontoone Trading Down 0.7%

NASDAQ BLLN opened at $138.60 on Friday. The company has a market cap of $6.37 billion and a price-to-earnings ratio of 252.00. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $140.21. The business has a 50 day moving average price of $113.36 and a 200-day moving average price of $93.29. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million during the quarter, compared to the consensus estimate of $95.81 million. During the same quarter in the prior year, the business earned ($0.39) earnings per share. Billiontoone’s revenue for the quarter was up 83.8% on a year-over-year basis. As a group, equities analysts expect that Billiontoone, Inc. will post 0.92 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. BTIG Research cut their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Guggenheim initiated coverage on shares of Billiontoone in a report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target for the company. Finally, JPMorgan Chase & Co. lifted their price target on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Billiontoone has a consensus rating of “Moderate Buy” and an average target price of $126.00.

Insider Buying and Selling at Billiontoone

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $102.27, for a total value of $2,045,400.00. Following the transaction, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at approximately $102,270. This trade represents a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of Billiontoone stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $110.00, for a total transaction of $880,000.00. Following the transaction, the insider owned 208,000 shares of the company’s stock, valued at $22,880,000. This represents a 3.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 153,049 shares of company stock worth $16,768,021. Corporate insiders own 50.22% of the company’s stock.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.